Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07195123 · ClinicalTrials.gov registry record · NA
Evaluation of the SMART IBD App in Pediatric IBD
A NA study of Ulcerative Colitis (UC) and Inflammatory Bowel Disease (IBD), sponsored by Children's Hospital Medical Center, Cincinnati.
- Recruiting
- Registry status
- NA
- Development phase
- 70
- Enrollment target
- 1
- Study location
NCT07195123: Recruiting NA study of Ulcerative Colitis (UC) and Inflammatory Bowel Disease (IBD), sponsored by Children's Hospital Medical Center, Cincinnati.
NCT07195123 is a NA study of Ulcerative Colitis (UC) and Inflammatory Bowel Disease (IBD) that is actively recruiting participants, run by Children's Hospital Medical Center, Cincinnati. The registered enrollment target is 70 participants, below the 761-participant average among 17 other Ulcerative Colitis (UC) trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07195123, a NA study of Ulcerative Colitis (UC) and Inflammatory Bowel Disease (IBD), is actively recruiting participants, sponsored by Children's Hospital Medical Center, Cincinnati.
- RECRUITING
- Registry status
- NA
- Development phase
- 70 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this trial is to test whether a smartphone app, SMART-IBD, is effective in improving medication adherence and self-management skills in adolescents with IBD. The investigators will conduct a randomized control trial to compare 35 youth (ages 13-17) with IBD using an app that contains daily symptom diaries, education content, medication reminders, as well as monthly engagement challenges to 35 youth in an attention control group that will complete daily diaries. The length of the intervention will include one month of baseline symptom and adherence collection, a baseline assessment, 5 months of intervention, and a post-treatment assessment.
Primary Outcome
Medication adherence will be measured by daily responses by participants to prompts in the SMART IBD app regarding whether each dose was taken for each medication. A mean adherence score will be calculated across medications for each participant for the 28 day periods at baseline and post-treatment.
Conditions Studied
Interventions
- BEHAVIORAL SMART-IBD
Study Locations (1)
Ohio
- Cincinnati Children's Hospital Medical Center - Cincinnati
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2025-10-23 |
| Est. Completion | 2027-08-31 |
| Phase | NA |
What NCT07195123 shows while recruiting
NCT07195123 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 70 participants, a relatively small participant target, below the 761-participant average among 17 other Ulcerative Colitis (UC) trials with a reported enrollment target (91% lower).
The record links to 6 conditions, with Ulcerative Colitis (UC) appearing as the primary indexed condition, and to 1 intervention - of which SMART-IBD is the first listed.
NCT07195123 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT07195123 about?
NCT07195123 is a clinical study titled "Evaluation of the SMART IBD App in Pediatric IBD". The objective of this trial is to test whether a smartphone app, SMART-IBD, is effective in improving medication adherence and self-management skills in adolescents with IBD. The investigators will conduct a randomized control trial to compare 35 youth (ages 13-17) with IBD using an app that contain...
What is the current status of trial NCT07195123?
This trial is currently recruiting. It is a NA study. The enrollment target is 70 participants. The study started on 2025-10-23. Estimated completion is 2027-08-31.
What conditions does trial NCT07195123 study?
This clinical trial studies the following conditions: Ulcerative Colitis (UC), Inflammatory Bowel Disease (IBD), Indeterminate Colitis, Crohn Disease (CD), IBD.
What interventions are being tested in trial NCT07195123?
The interventions under investigation include: SMART-IBD (BEHAVIORAL).
Who is sponsoring clinical trial NCT07195123?
This trial is sponsored by Children's Hospital Medical Center, Cincinnati, which has 571 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07195123 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ulcerative Colitis (UC)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07195123's enrollment target sits among peer trials
70 13th of 17 higher than 5 of 17 other Ulcerative Colitis (UC) trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Ulcerative Colitis (UC) trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
STOP-UC: De-escalation of Therapy in Patients With Ulcerative Colitis With Histological Remission
RECRUITING · NA
-
Use of Psychologist-administered Cognitive Behavioral Therapy (CBT) or Self-administered CBT for the Treatment of Anxiety and/or Depression in Inflammatory Bowel Disease (IBD)
RECRUITING · NA
-
Supplementation of Vitamin D3 in Patients With Inflammatory Bowel Diseases and Hypovitaminosis D
COMPLETED · NA
-
Zymfentra (Infliximab-dyyb) REal World Cohort STudy
RECRUITING
-
Selenium Supplementation in Moderate-Severely Active Ulcerative Colitis Patients Treated With Advanced Therapies
RECRUITING · Phase 2
-
Evaluate the Safety, Tolerability, PK and PD of SAD of Intravenously Adminsterted ALTB-268 in Healthy Participants
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00969111 · 70 participants · NA
Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
- NCT01712620 · 70 participants · Phase 2
Spironolactone for Pulmonary Arterial Hypertension
- NCT02143830 · 70 participants · Phase 2
HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy
- NCT02601339 · 70 participants
NIRS Monitoring in Premature Infants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI